AzTrials
AzTrials

Postoperative PainNCT04443556

Effect of Continue RISS Block in Thoracotomy

A study testing Tramadol and IV PCA in people with Postoperative Pain and Thoracotomy, run by Konya Meram State Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Thoracotomy is one of the most painful surgery. Acute postoperative pain increases postoperative morbidity and prolongs hospital stay and also may lead to developing a chronic pain syndrome. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Postoperative Pain, Thoracotomy
What is being tested?
Tramadol and IV PCA
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
31 Aug 2020to 15 Feb 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients over 18 years of age undergoing elective thoracic surgery
  • American Society of Anesthesiologists (ASA) physical status I-III grade

Who cannot join

  • Patient refusal
  • History of psychiatric and cognitive disorders.
  • Patients allergic to the drugs used in the study
  • Emergent surgery

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Konya Education and Training Hospital

    Konya

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Continue Rhomboid Intercostal and Subserratus Plane Block in Thorocotomy

Thoracotomy is one of the most painful surgery. Acute postoperative pain increases postoperative morbidity and prolongs hospital stay and also may lead to developing a chronic pain syndrome. This study aimed to assess the efficacy of continuous rhomboid intercostal and subserratus plane (RISS) block by inserting a catheter under direct vision for controlling acute thoracotomy pain.

Read the detailed description

Before the closure of the thoracotomy, the surgeon will place two catheters through a Tuohy needle into fascial planes for continue RISS block. First catheter tip will be place towards the interfascial planes between the rhomboid major and intercostal muscles and the second catheter tip will be place in subserratus fascial plane. Continue local anesthetics will be injected through the catheters for 48 hours.

Being tested
Tramadol, IV PCA
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TramadolDrug

    Also called Local anesthetic

    Before the closure of the thoracotomy, the surgeon will place two catheters through a Tuohy needle into fascial planes for continue the RISS block. First catheter tip will be placed towards the interfascial planes between the rhomboid major and intercostal muscles and the second catheter tip will be placed in subserratus fascial plane. Continue local anesthetics will be injected through the catheters for 48 hours. Also an IV patient-controlled analgesia device containing tramadol will be provided. Tramadol consumptions and postoperative numeric rating scale (NRS) scores for pain will be recorded.

  • IV PCAOther

    An IV patient-controlled analgesia device containing tramadol will be provided. Tramadol consumptions and postoperative numeric rating scale (NRS) scores for pain will be recorded.

Study groups in NCT04443556
Study groupRoleWhat they receive
Group Rhomboid Intercostal and Subserratus Plane BlockActive comparatorStandart postoperative analgesia + Continue Rhomboid Intercostal and Subserratus Plane Block
Receives: Drug: Tramadol; Other: IV PCA
Control GroupOtherStandart postoperative analgesia
Receives: Other: IV PCA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. postoperative pain

    Numeric rating scale (NRS) NRS use numbers to rate pain from 0 (no pain) to 10 (worst pain).

    Measured: postoperative 48 hour

Secondary outcomes (1)
  1. Analgesic consumption

    Total opioid consumption after the surgery

    Measured: Postoperative 48 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2020
  2. Study start31 Aug 2020
  3. Primary completion30 Jan 2021
  4. Study completion15 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04443556
Sponsor's protocol ID
RISS THORACOTOMY
Status last verified
Apr 2021
First submitted
20 Jun 2020
Last updated
20 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Tramadol and IV PCA in people with Postoperative Pain and Thoracotomy, run by Konya Meram State Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

postoperative pain (time frame: postoperative 48 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Apr 2021; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in